Meta recently open-sourced Brain2Qwerty v2, a noninvasive Brain–Computer Interface (BCI) that can decode sentences from ...

Researchers have identified a vitamin B12–based compound that can cross the blood-brain barrier and home in on glioblastoma tumors. In animal studies, the compound accumulated preferentially in tumor ...

A 60-year-old man in Spain went to the doctor complaining of a headache that he couldn’t shake. It had started two weeks prior and was only getting worse. He also said he had noticed subtle changes in ...

Researchers at Oregon State University have potentially found a new way to treat the most aggressive form of brain cancer, glioblastoma, whose two-year survival rate is less than 30%. The study, led ...

The startup Coherence Neuro is now testing a brain-computer interface that could one day use electrical stimulation to prevent tumors from growing. Coherence Neuro says it temporarily placed its ...

Novocure’s tumor-treating electric fields device missed its primary endpoint in a late-stage glioblastoma trial. The Swiss medtech’s product has an FDA approval as Optune Gio. The device is licensed ...

The following is a summary of a story by Adriana Difranco on MADE FOR THIS. Chemotherapy drugs for brain tumors typically haven’t been able to get past the blood-brain barrier, says Duke neurosurgeon ...

As the state investigates a possible cancer cluster at a high school, many Herald readers have asked whatever happened with the potential tumor cluster at a local hospital. Seven current and former ...

A new report on the investigation into a potential hospital cancer cluster is shedding light on the 11 nurses who were diagnosed with brain tumors. Eleven current and former nurses in Newton-Wellesley ...

Stephen De La Torre's brain tumor was the size of a battery and close to his brain stem, so doctors found a way to shrink the cancer — and avoid exposing healthy tissues to radiation Kurt ...

Professor Richard Scolyer, renowned pathologist and joint Australian of the Year (2024), has died at the age of 59. Scolyer captured the attention of Australians and the world when he volunteered to ...

June 3 (Reuters) - Today we revisit the American Society of Clinical Oncology scientific meeting in Chicago, which concluded on Tuesday, to report on three more potentially practice-changing studies.